Comparative study of the effect of rivaroxaban and fondaparinux on monocyte’s coagulant activity and cytokine release-Reference-Cited by-同舟云学术

Comparative study of the effect of rivaroxaban and fondaparinux on monocyte’s coagulant activity and cytokine release

Published:2014-12 Issue:1 Volume:3 Page:
ISSN:2162-3619
Container-title:Experimental Hematology & Oncology
language:en
Short-container-title:Exp Hematol Oncol

Author:

Laurent Marc,Joimel Ulrich,Varin Rémi,Cazin Lionel,Gest Caroline,Le-Cam-Duchez Veronique,Jin Jian,Liu Jielin,Vannier Jean-Pierre,Lu He,Soria Jeannette,Li Hong,Soria Claudine

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology

Link

https://link.springer.com/content/pdf/10.1186/2162-3619-3-30.pdf

Reference60 articles.

1. Hirsh J, O'Donnell M, Weitz JI: New anticoagulants. Blood 2005, 105: 453–463. 10.1182/blood-2003-12-4195

2. Beguin S, Choay J, Hemker HC: The action of a synthetic pentasaccharide on thrombin generation in whole plasma. Thromb Haemost 1989, 61: 397–401.

3. Lormeau JC, Herault JP: The effect of the synthetic pentasaccharide sr 90107/org 31540 on thrombin generation ex vivo is uniquely due to ATIII mediated neutralization of factor Xa. Thromb Haemost 1995, 74: 1474–1477.

4. Perzborn E, Strassburger J, Wilmen A, Pohlmann J, Roehrig S, Schlemmer KH, Straub A: In vitro and in vivo studies of the novel antithrombotic agent bay 59–7939–an oral, direct factor a inhibitor. J Thromb Haemost 2005, 3: 514–521. 10.1111/j.1538-7836.2005.01166.x

5. Mann KG, Brummel K, Butenas S: What is all that thrombin for? J Thromb Haemost 2003, 1: 1504–1514. 10.1046/j.1538-7836.2003.00298.x

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological dynamics in the contact, coagulation, and complement systems during sepsis: Potential targets for nafamostat mesilate;Journal of Intensive Medicine;2024-10

2. Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling;International Journal of Molecular Sciences;2024-08-10

3. Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism;PROTEOMICS – Clinical Applications;2024-01-09

4. Acute Pulmonary Embolism and Immunity in Animal Models;Archivum Immunologiae et Therapiae Experimentalis;2024-01-01

5. TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol;BMJ Open;2023-10